Metaxalone Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

Report Code: HCR 65477 Report Format: PDF + Excel (Delivery in 48 Hrs)

Metaxalone Market Overview

Metaxalone Market size is estimated to reach $5,770 million by 2026, growing at a CAGR of 6% during 2021-2026 forecast period. Metaxalone is a muscle relaxant medication that is administered orally and is used to reduce pain and relax muscles which is caused by strain and other musculoskeletal conditions. Metaxalone works by blocking nerve impulses in the brain and is used as muscle relaxation method. Metaxalone is also called skelaxin which is used for muscle spasms and musculoskeletal pain. Metaxalone is also a mixture of two enantiomers such as R- metaxalone and X-metaxalone which is approved by the Food and Drug Administration (FDA). 
The chemical name of metaxalone is oxazolidinone which acts in the central nervous system to produce the muscle relaxant effects. Growing number of musculoskeletal disorders among people and growing number of road accidents is the major factor driving the growth of this market. Furthermore, increasing research and development activities regarding drugs and rising geriatric population is set to further enhance the overall market demand for Metaxalone Market for the period 2021-2026.

Report Coverage

The report: “Metaxalone Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Metaxalone Market.   
By Indication: Bone Pain, Muscle Pain, Tunnel Syndrome, Joint Pain, and Others
By End-Use Industry: Hospitals, Clinics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, North America dominated the Metaxalone Market owing to presence of advanced healthcare system and rising development in pharmaceutical industry.
  • Growing number of musculoskeletal disorders among people and growing number of road accidents are likely to aid in the market growth of the Metaxalone. 
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Metaxalone Market report.  
  • Increasing side effects is set to create hurdles for the Metaxalone Market.   

Metaxalone Market Size, By End-Use Industry 2020-2026 (USD million)

Metaxalone Market

For more details on this report - Request for Sample

Metaxalone Segment Analysis – By Indication

The global Metaxalone Market based on Indication can be further segmented into Bone Pain, Muscle Pain, Tunnel Syndrome, Joint Pain, and Others. The Bone Pain segment is the major segment generating revenue in 2020. This is owing to increasing cases of arthritis owing to unhealthy lifestyle. Moreover, increasing outdoor activities increases the demand of metaxalone. The Muscle Pain segment is estimated to register the fastest CAGR of 2.5% for the period 2021-2026. Metaxalone is considered as muscle relaxant which is used to reduce musculoskeletal pain and hence the growth of the segment is rising.

Metaxalone Segment Analysis – By End-Use Industry

The global Metaxalone Market based on End-Use Industry can be further segmented into Hospitals, Clinics, and Others. The Hospital segment registers for the Metaxalone highest market share in 2020. This is owing to easy accessibility of hospital and higher selling capacity. Moreover, owing to the availability of skilled professionals, patients can prefer hospitals and are rising the growth of this segment. The Clinics segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to clinics that are opened for more time increasing the selling capacity and also provide fast service which increases the demand of metaxalone and leading to market growth.

Metaxalone Segment Analysis – By Geography

North America dominated the Metaxalone Market with major share of 40% in 2020. This is owing to presence of advanced healthcare system and rising development in pharmaceutical industry. According to American Hospital Association, in 2019 about 6,090 hospitals are identified that focus on the development in healthcare system and are leading to the rising the growth of this segment. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare. 

Metaxalone Market Drivers

Growing Number of Musculoskeletal Disorders 

Growing number of patients associated with musculoskeletal disorders such as arthritis increases the growth of the Metaxalone Market. According to World Health Organization, about 1.71 billion people may have musculoskeletal conditions in 2021 that increases the demand of metaxalone market. Moreover, increasing number of incidents resulting in injury and growing number of athlete gym is rising the demand of treatment and are increasing the growth of the Metaxalone Market over 2021-2026. 

Growing Number of Road Accidents

Rising number of road accidents owing to lack of adequate facilities increases the growth of the Metaxalone Market. According to World Health Organization, about 1.35 million are injured owing to road accidents in 2020 that increases the use of oxazolidinone for the treatment of pain and are increases the growth of Metaxalone Market over 2021-2026.  

Covid-19 Impact: 

COVID-19 pandemic had greatly affected the Metaxalone Market. Owing to pandemic, there is lockdown that reduces the vehicles on the road which reduces accidents that hamper the growth of this market. Moreover, reduction of numerous outdoor activities including sports and gymnasiums has significantly impacted demand for metaxalone as it provides muscle relaxation and are negatively impacted the growth of this market. 

Metaxalone Market Challenges

Increasing Side Effects

The factors that is set to impede the growth of the Metaxalone Market are increasing side effects such as vomiting, headache, nausea, and irritability etc. Moreover, stringent government approval is set to create hurdles for the Metaxalone Market. 

Metaxalone Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Metaxalone Market. Metaxalone top 10 companies include, Biosynth, Chunghwa Chemical Synthesis & Biotech Co., Ltd., Sigma-Aldrich Co. LLC, CDI Technology, Angelini S.p.A., Pfizer Inc., Aurum Pharmatech LLC, Finetech Industry Limited, Biocore, and Oxchem Corporation.

Developments

  • In 30 July 2019, Chunghwa Chemical Synthesis & Biotech Co., Ltd is working on the development of metaxalone in order to reduce musculoskeletal pain and are rising the growth of this market.

Relevant Reports:

Report Code: HCR 0323

Report Code: HCR 0924

For more Lifesciences and Healthcare Market reports, please click here
1. Metaxalone Market Overview
    1.1 Definitions and Scope
2. Metaxalone Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Indication
    2.3 Key trends by End-Use Industry
    2.4 Key trends by Geography
3. Metaxalone Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Metaxalone Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Metaxalone Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Metaxalone Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Metaxalone Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Metaxalone Market– By Indication (Market Size -$Million/$Billion)
    8.1 Bone Pain
    8.2 Muscle pain
    8.3 Tunnel Syndrome
    8.4 Joint Pain
    8.5 Others
9. Metaxalone Market– By End-Use Industry (Market Size -$Million/$Billion)
    9.1 Hospitals
    9.2 Clinics
    9.3 Others
10. Metaxalone Market- By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 Italy
        10.2.4 France
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Australia
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 India
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Others
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Metaxalone Market Entropy
12. Metaxalone Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Metaxalone Market- Key Company List by Country Premium Premium
14. Metaxalone Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
1.1 BONE PAIN Market 2019-2024 ($M) - Global Industry Research
1.2 MUSCLE PAIN Market 2019-2024 ($M) - Global Industry Research
1.3 JOINT PAIN Market 2019-2024 ($M) - Global Industry Research
1.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Global Industry Research
2.Global METAXALONE MARKET, BY INDICATION Market 2019-2024 (Volume/Units)
2.1 BONE PAIN Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 MUSCLE PAIN Market 2019-2024 (Volume/Units) - Global Industry Research
2.3 JOINT PAIN Market 2019-2024 (Volume/Units) - Global Industry Research
2.4 TUNNEL SYNDROMES Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
3.1 BONE PAIN Market 2019-2024 ($M) - Regional Industry Research
3.2 MUSCLE PAIN Market 2019-2024 ($M) - Regional Industry Research
3.3 JOINT PAIN Market 2019-2024 ($M) - Regional Industry Research
3.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Regional Industry Research
4.South America METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
4.1 BONE PAIN Market 2019-2024 ($M) - Regional Industry Research
4.2 MUSCLE PAIN Market 2019-2024 ($M) - Regional Industry Research
4.3 JOINT PAIN Market 2019-2024 ($M) - Regional Industry Research
4.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Regional Industry Research
5.Europe METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
5.1 BONE PAIN Market 2019-2024 ($M) - Regional Industry Research
5.2 MUSCLE PAIN Market 2019-2024 ($M) - Regional Industry Research
5.3 JOINT PAIN Market 2019-2024 ($M) - Regional Industry Research
5.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Regional Industry Research
6.APAC METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
6.1 BONE PAIN Market 2019-2024 ($M) - Regional Industry Research
6.2 MUSCLE PAIN Market 2019-2024 ($M) - Regional Industry Research
6.3 JOINT PAIN Market 2019-2024 ($M) - Regional Industry Research
6.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Regional Industry Research
7.MENA METAXALONE MARKET, BY INDICATION Market 2019-2024 ($M)
7.1 BONE PAIN Market 2019-2024 ($M) - Regional Industry Research
7.2 MUSCLE PAIN Market 2019-2024 ($M) - Regional Industry Research
7.3 JOINT PAIN Market 2019-2024 ($M) - Regional Industry Research
7.4 TUNNEL SYNDROMES Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Metaxalone Market Revenue, 2019-2024 ($M)
2.Canada Metaxalone Market Revenue, 2019-2024 ($M)
3.Mexico Metaxalone Market Revenue, 2019-2024 ($M)
4.Brazil Metaxalone Market Revenue, 2019-2024 ($M)
5.Argentina Metaxalone Market Revenue, 2019-2024 ($M)
6.Peru Metaxalone Market Revenue, 2019-2024 ($M)
7.Colombia Metaxalone Market Revenue, 2019-2024 ($M)
8.Chile Metaxalone Market Revenue, 2019-2024 ($M)
9.Rest of South America Metaxalone Market Revenue, 2019-2024 ($M)
10.UK Metaxalone Market Revenue, 2019-2024 ($M)
11.Germany Metaxalone Market Revenue, 2019-2024 ($M)
12.France Metaxalone Market Revenue, 2019-2024 ($M)
13.Italy Metaxalone Market Revenue, 2019-2024 ($M)
14.Spain Metaxalone Market Revenue, 2019-2024 ($M)
15.Rest of Europe Metaxalone Market Revenue, 2019-2024 ($M)
16.China Metaxalone Market Revenue, 2019-2024 ($M)
17.India Metaxalone Market Revenue, 2019-2024 ($M)
18.Japan Metaxalone Market Revenue, 2019-2024 ($M)
19.South Korea Metaxalone Market Revenue, 2019-2024 ($M)
20.South Africa Metaxalone Market Revenue, 2019-2024 ($M)
21.North America Metaxalone By Application
22.South America Metaxalone By Application
23.Europe Metaxalone By Application
24.APAC Metaxalone By Application
25.MENA Metaxalone By Application
26.BIOSYNTH, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.CHUNGHWA CHEMICAL SYNTHESIS BIOTECH CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.SIGMA-ALDRICH CO. LLC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.CDI TECHNOLOGY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.ANGELINI S.P.A., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.PFIZER INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.AURUM PHARMATECH LLC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.FINETECH INDUSTRY LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.BIOCORE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.OXCHEM CORPORATION, Sales /Revenue, 2015-2018 ($Mn/$Bn)